Tag: Hatch-Waxman
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
10 Apr 2026
Priority vs Standard Review: How the FDA Speeds Up Generic Drug Approvals
-
19 Jun 2026
How and Where to Buy Sildalis Online Safely in 2026
-
26 Jul 2025
titans.to Online Pharmacy Review: Is It Safe, Reliable, and Worth Your Time?
-
3 Jan 2026
Drug Holidays: When Taking a Break from Medication Is Safe and Smart
-
9 Jan 2026
Fluoxetine or Paroxetine with Codeine: Why Your Pain Relief Might Vanish